Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.

You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-NP-G2-029
NP-G2-029

Chemical Structure : NP-G2-029

CAS No.: 1807454-44-9

NP-G2-029

Catalog No.: PC-24546Not For Human Use, Lab Use Only.

NP-G2-029 is a specific small molecule inhibitor of Fascin (FSCN1) with IC50 of 0.19 uM in F-actin-bundling assay, decreases the migration of mouse and human breast tumor cells.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
250 mg Get quote

Bulk size, bulk discount!

Welcome credit card payment!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

NP-G2-029 is a specific small molecule inhibitor of Fascin (FSCN1) with IC50 of 0.19 uM in F-actin-bundling assay, decreases the migration of mouse and human breast tumor cells.
NP-G2-029 decreases the actin-bundling activity of fascin and tumor cell migration.

Physicochemical Properties

M.Wt 400.36
Formula C20H15F3N4O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

4-methyl-N-(1-(4-(trifluoromethyl)benzyl)-1H-indazol-3-yl)isoxazole-5-carboxamide

References

1. Lirui Lin, et al. Front Chem. 2021 Oct 7:9:719949.

2. Gong R, et al. Nat Struct Mol Biol. 2025 Jan 20. doi: 10.1038/s41594-024-01477-2.

3. Huang J, et al. J Mol Biol. 2018 Apr 27;430(9):1324-1335.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: